Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Update on Continuation Proposals

14 Jan 2016 07:00

RNS Number : 8126L
BlueCrest AllBlue Fund Ltd
14 January 2016
 



 

BlueCrest AllBlue Fund Limited (the "Company")

14 January 2016

Update on Continuation Proposals

Further to the Company's announcement on 9 December 2015, the Board is pleased to announce that, having completed its review of manager proposals received by the Company and consulted with its major shareholders, it proposes to recommend the replacement of its existing management arrangements with a mandate given to J.P. Morgan Asset Management ("JPMAM") group(1). The proposed appointment is subject to, amongst other things, detailed due diligence which is being performed on behalf of the Company and finalisation of engagement terms. In addition, the proposed appointment will be subject to shareholder approval as part of the re-organisation proposals (the "Proposals") to be put forward in due course.

As part of the Proposals, it is intended that the Company will invest substantially all of its assets (net of the cash exit opportunity described below) in the Highbridge Multi-Strategy Fund ("HMSF"). HMSF is a global multi-strategy hedge fund, managed by Highbridge Capital Management ("HCM"), focused on relative value strategies with idiosyncratic sources of return that invests in 12 distinct strategies across Fundamental Equity, Quantitative Equity, Event Driven Equity, Capital Structure Arbitrage, Convertible & Volatility Arbitrage, Fundamental Credit and Macro. Since its inception (1 January 1993) HMSF has achieved 10.76% annualised net returns, 6.89% annualised volatility and low beta relative to equity and credit indices.(2)

The JPMAM group is the largest manager of closed-end investment companies in the UK with 23 investment companies under its management and £9.2bn of assets under management(3). HCM was founded in 1992 as one of the industry's first multi-strategy hedge fund managers. Today, it is a global alternative investment manager with $29 billion in AUM(4). HCM maintains a staff of over 380 employees, including ~150 investment professionals and has offices in London, New York and Hong Kong.(4) HCM established a strategic partnership with JPMAM in 2004. All investment, capital allocation and risk management decisions for HMSF are independent of JPMAM.

It is currently intended to put forward the Proposals by the end of January/early February. As previously announced, the Proposals will provide shareholders with an opportunity to receive a full cash exit at NAV less costs (the "Cash Exit"), representing the net realisation proceeds from the AllBlue Limited redemptions, as soon as practicable following receipt by the Company. Proceeds of AllBlue Limited assets not capable of immediate realisation will subsequently be invested into HMSF with the exception of those proceeds due to shareholders pursuant to the Cash Exit.

Following implementation of the Proposals, it is intended to introduce a quarterly redemption facility, for up to 20% of the prevailing net asset value of the Company at NAV less costs, which may be implemented at the Board's discretion in each quarterly period. It is intended that net redemption proceeds would be paid to shareholders as soon as practicable following receipt by the Company.

A further announcement in relation to the Proposals will be made in due course.

For further information contact:

JTC (Guernsey) Limited, Secretary

Tel: +44 (0) 1481 702 400

Jefferies International Limited

Gary Gould/ Alex Collins

Tel: + 44 (0) 20 7029 8000

Dexion Capital Plc

Robin Bowie/ Katie Standley

Tel: +44 (0) 20 7832 0900

 

 

PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE RESULTS

There can be no assurance that the Company's or HMSF's return objectives will be realized or that the Company or HMSF will not experience losses.

 

(1) The brand name for the Asset Management business of J.P. Morgan Chase & Co.

(2) As of 30 November 2015 net of all applicable fees and expenses. Returns are estimated and unaudited for 2015.

(3) As of 31 December 2015.

(4) As of 1 December 2015.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRUOUKRNWAAAAR
Date   Source Headline
8th Dec 20219:50 amRNSAquisition of Praxis Fund Services by Sanne Group
3rd Dec 20217:00 amRNSCompany Update
2nd Dec 20213:12 pmRNSNet Asset Value(s)
2nd Dec 20213:12 pmRNS2019 Redemption Portfolio
30th Nov 20214:00 pmRNSTotal Voting Rights
24th Nov 20211:04 pmRNSDirector/PDMR Shareholding
5th Nov 20215:06 pmRNSReturn of Capital to Shareholders
2nd Nov 20214:18 pmRNS2019 Redemption Portfolio
2nd Nov 20214:17 pmRNSNet Asset Value(s)
28th Oct 202112:31 pmRNSResult of AGM
7th Oct 202111:51 amRNSHolding(s) in Company
7th Oct 20217:00 amRNSNotice of AGM
6th Oct 202111:50 amRNSHolding(s) in Company
1st Oct 20211:11 pmRNSNet Asset Value(s)
1st Oct 202112:55 pmRNS2019 Redemption Portfolio
20th Sep 20213:48 pmRNSHalf-year Report
14th Sep 20212:21 pmRNSDirector/PDMR Shareholding
1st Sep 20212:58 pmRNS2019 Redemption Portfolio
1st Sep 20212:55 pmRNSNet Asset Value(s)
31st Aug 20214:40 pmRNSHolding(s) in Company
27th Aug 20217:00 amRNSHolding(s) in Company
19th Aug 20214:00 pmRNSTotal Voting Rights
12th Aug 20214:00 pmRNSReturn of Capital to Shareholders
4th Aug 20215:07 pmRNS2019 Redemption Portfolio
4th Aug 202110:23 amRNSNet Asset Value(s)
27th Jul 20219:15 amRNSDirector Declaration
5th Jul 202112:15 pmRNSApproximate Asset Exposure of the Company
29th Jun 20214:44 pmRNS2019 Redemption Portfolio
29th Jun 20214:38 pmRNSNet Asset Value - Month End Final
21st Jun 20218:31 amRNSDirector/PDMR Shareholding
28th May 20214:30 pmRNSTotal Voting Rights
27th May 20217:00 amRNSHolding(s) in Company
25th May 20214:57 pmRNS2019 Redemption Portfolio
25th May 20214:54 pmRNSNet Asset Value - Month End Final
25th May 20217:00 amRNSDirector/PDMR Shareholding
17th May 202112:54 pmRNSReturn of Capital to shareholders
6th May 20214:48 pmRNSNet Asset Value - Month End Final
6th May 20214:48 pmRNS2019 Redemption Portfolio
22nd Apr 20213:24 pmRNSReturn of Capital to Shareholders
22nd Apr 20217:00 amRNSAnnual Report and Financial Statements
25th Mar 20215:15 pmRNS2019 Redemption Portfolio
25th Mar 20215:14 pmRNSNet Asset Value - Month End Final
5th Mar 20214:51 pmRNS2019 Redemption Portfolio
5th Mar 20214:50 pmRNSNet Asset Value - Month End Final
26th Feb 20214:20 pmRNSTotal Voting Rights
26th Feb 20217:00 amRNSDirector/PDMR Shareholding
19th Feb 20214:38 pmRNSReturn of Capital to Shareholders
19th Feb 20211:10 pmRNSNet Asset Value - Weekly Estimate
18th Feb 20215:12 pmRNSHolding(s) in Company
16th Feb 20211:48 pmRNSNet Asset Value - Weekly Estimate

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.